ckcf2018

Login prior to clicking the links below

SESSION I – IMMUNOTHERAPY UPDATES

   
Welcome and Introduction of Program Co-Chairs Anil Kapoor VIEW
Welcome: Overview Of Program, Speakers and Meeting Objectives Simon Tanguay, Lori Wood VIEW
Immune Checkpoint Blockers: Today and Tomorrow Manuela Schmidinger VIEW
Decoding the Discussion Between the Immune System and Tumors: A Translator Perspective Réjean Lapointe VIEW
     

SESSION II – CURRENT RESEARCH IN CANADA

   
CKCis Update Report: Data, Recent Publications and Ongoing Research Naveen Basappa, Rodney Breau VIEW
Renal TRACERx: Deterministic Evolutionary Trajectories Govern Primary Tumour Growth Samra Turajlic VIEW

Highlights in Kidney Cancer Research in Canada    
Renal Cell Carcinoma in the Canadian Indigenous Population Emily Wong (McMaster) VIEW
Overexpression of MIR-2355 Revealed SUSD4 as Predicted Target in VHL-Inactivated Renal Cell Carcinoma Sandra Turcotte (Université de Moncton) VIEW
Development of a Patient Decision Aid for Complex, Localized Renal Masses Kristen McAlpine (University of Ottawa) VIEW
Exploiting Novel Therapeutic Targets to Block Metastasis of Clear Cell Renal Cell Carcinoma Jan Rudzinski (University of Alberta) VIEW

Immune Checkpoint Blockades in the Clinic: Unanswered Questions, Optimizing Use, and Patterns of Response Toni Choueiri VIEW

Spotlight on KCRNC-Research Trainees    
Identification and Translation of Novel Kidney Cancer Immunotherapeutic Targets Through Genetic Screens Using the CRISPR-Cas9 System Keith Lawson (University of Toronto) VIEW
Understanding the Attributes of Papillary Renal Cell Carcinoma Subtypes: Molecular Analysis, Biomarker Discovery and Implications to Therapy Rola Saleeb (St. Michael’s Hospital) VIEW
Genomics Analysis with Functional Imaging of RCC Patient Derived Xenografts (PDXs) to Determine If There Are Key Genetic Mutations That Are Responsible For a Drug Resistant Phenotype. Matthew Lowerison (University of Western Ontario) VIEW

Clinical Trials Update, Opportunities, and Ongoing Projects in Canada Christian Kollmannsberger VIEW
     

LATE BREAKING CANADIAN PROJECTS

   
Results from Renal Hypothermia During Partial Nephrectomy Ilias Cagiannos, Rodney Breau VIEW
2017 CUA Follow-Up Guidelines for Resected RCC Wes Kassouf VIEW
Kidney Cancer Canada Updates Stephen Andrew, Andrew Weller VIEW
     

SESSION III: CLINICAL AND BIOLOGICAL GENETICS and BIOMARKERS

   
Contemporary Role of Cytoreductive Nephrectomy Stephen Boorjian VIEW
Tracking Renal Cancer Evolution Reveals Constrained Routes to Metastases Samra Turajlic VIEW
Precision Medicine from the Renal Cancer Genome Yasser Riazalhosseini VIEW
Emerging Biomarkers of Immune Checkpoint Markers in RCC Toni Choueiri VIEW
     

SESSION V: MOVING FORWARD

   

Grant Presenters:    
Identifying Prognostic and Predictive Biomarkers in Metastatic Renal-Cell Carcinoma: An Exploratory Study of the International Metastatic Renal‐Cell Carcinoma Database Consortium (IMDC) Tissue Biorepository Shaan Dudani VIEW
The Preclinical Development of a Novel Formulation to Silence the Expression of Proteins Required for Renal Cell Carcinoma Metastasis Jan Krzysztof Rudzinski VIEW
Surveillance of Complex Renal Cysts – The SoCRAtiC Pilot Trial Patrick Richard VIEW
Assessing Glioma-Protein Inhibition in Sunitinib-Resistance Using a Tissue-Engineered RCC Patient Derived 3-Dimensional Model Ninadh D’costa VIEW
Discussion and Q & A   VIEW

Retroperitoneal Lymph Node Dissection For Renal Cell Carcinoma: Yes, No, or Sometimes? Stephen Boorjian VIEW
     
Group 1: Moving Forward with Clinical Genetics Raymond Kim, Alan So VIEW
Group 2: Understanding and Improving Survivorship Issues Jennifer Jones, Christina Canil VIEW
Group 3: Optimizing/Personalizing RCC therapy Georg Bjarnason, Sebastien Hotte VIEW
Group 4: Advancing Diagnostic Abilities and Techniques in RCC Luke Lavallée, Pierre Karakewicz VIEW
     
Progress Report, Grant Winners and Future Discussion Anil Kapoor VIEW

Mobile Login Form

Login to view videos. Members - Contact denise.toner@cua.org for your password | Meeting participants contact tal.erdman@cua.org